Tower Research Capital LLC (Trc) Innoviva, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Innoviva, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 693 shares of INVA stock, worth $13,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
693
Previous 4,962
86.03%
Holding current value
$13,270
Previous $86,000
86.05%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding INVA
# of Institutions
256Shares Held
75MCall Options Held
2.3KPut Options Held
2.4K-
Black Rock Inc. New York, NY9.63MShares$184 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.3MShares$121 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$120 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.66MShares$89.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.56MShares$87.3 Million0.13% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.33B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...